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Abstract
Background: Oral leukoplakia (OL) is the best-known potentially malignant disorder. The objective of the current study was
to evaluate the clinicopathological factors predictive of outcome in a large cohort of patients with OL, and report our
experience in the early detection of malignant events.
Methods: A total of 320 patients with biopsy-proven OL were retrospectively reviewed from the study institution who had a
mean follow-up of 5.1 years. Data on patient and lesion at initial diagnosis and patient underwent sequential biopsies were
reviewed. Multiple biopsies indicates .=3 times sequential biopsies. Oral cancer-free survival rate (OCFS) was determined
by the Kaplan-Meier method and significant factors were identified by Cox regression analysis.
Results: The 3-year and 5-year OCFS was 86.6% and 82.0%, respectively. A new binary system of grading oral dysplasia was
performed and Kaplan-Meier analysis indicated that high-grade dysplasia had significantly higher malignant incidence than
low-grade dysplasia (5-year OCFS, 90.5% vs 59.0%; P,0.001), especially during the first 2–3 years of follow-up. Multivariate
analysis revealed that the 4 factors including patient aged .60 years, lesion located at lateral/ventral tongue, non-
homogenous lesion, high-grade dysplasia were independent significant indicators for OL malignant transformation. In
addition, significant positive correlation between the multiple biopsies and these 4 factors and malignant outcome was
established.
Conclusions: Elderly patients with OL located at lateral/ventral tongue and who had non-homogenous lesion with high-
grade dysplasia correlated much higher risk of transformation. This high-risk subpopulation was suggested to undergo
sequential biopsies and histologic examination contributing to early detection of malignant event.
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Introduction
Oral cancer is the sixth most frequent leading cause of cancer
death worldwide; the early detection of malignant events is a high
priority for reducing deaths due to oral cancer. Oral squamous cell
carcinoma (OSCC) is the most frequent form (.90%) of oral
cancer, with 5-year survival rate of ,50% despite various
management in the past 3 decades [1–3]. It is widely accepted
that development of OSCC in potentially malignant lesions evolve
through a multistep process followed by varying grades of
epithelial dysplasia and invasive carcinoma [4–6]. Thus, biopsy
is supported as the standard for detecting dysplasia and carcinoma
in oral lesions, and histologic assessment of oral dysplasia is
currently the gold standard for determining the risk of malignant
transformation. But whether the grade of oral dysplasia is
significantly associated with malignant transformation remains a
considerable source of debate [6–13]. Therefore, further studies
are warranted to improve of histologic assessment of dysplasia.
Oral leukoplakia (OL) is defined as ‘‘A white plaque of
questionable risk having excluded (other) known diseases or
disorders that carry no increased risk for cancer’’ [14]. It is the
most common oral potentially malignant lesion, with a higher
tendency of malignant transformation increased with follow-up
years [15]. Unfortunately, the risk of OL transformation is difficult
to assess. Napier and Speight [16] recently reviewed clinical risk
factors of OL transformation, e.g. gender, age, lesion type and
location, but the results from different study populations vary. The
role of tobacco and alcohol use as carcinogens related to OL
malignant transformation remains controversial [17–20]. Hence,
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34773assessment of these potential risk factors for oral cancer
development in patients with OL is still needed.
The literature focusing on longitudinal observational study of a
comprehensive analysis of the clinicopathological factors predic-
tive of outcome in patients with OL is not robust [19–21], whereas
large cohort of patients are required to produce meaningful data
supported by robust statistical analysis. Therefore the objective of
the current study was to determine the clinicopathological factors
predictive of outcome in a large cohort of patients with OL who
received long-term follow-up (mean, 5.1 years; range, 1–20 years),
and to report our experience in the early detection of malignant
events in a hospital-based study of an ethnic Chinese population.
Methods
Patient Population
All 320 patients with biopsy-proven OL in this study were
retrospectively reviewed among the archived files at the Depart-
ments of Oral Mucosal Diseases and Oral Pathology, Shanghai
Ninth People’s Hospital, Shanghai Jiao Tong University School of
Medicine (SJTU-SM) from 1990 to 2010. All clinical information
and follow-up data were obtained from the files. In our clinic,
periodic follow-up examinations at intervals of every 6 months or
fewer were recommended for patients with OL. Data on gender,
age, lesion site, lesion type, history of smoking and alcohol intake
at the initial diagnosis of OL was all reviewed. Clinically, OL were
subdivided in a homogeneous type (flat, thin, and uniform) and a
non-homogeneous type (verrucous, speckled, or nodular). For all
the subjects, the treatments were grouped into medication (vitamin
A/Chinese herb, n=261) and surgery (n=59). According to the
World Health Organization (WHO) definition of OL [14], the
exclusion criteria were as follows: (i) Any patient with a diagnosis
of OL concomitant OSCC at the first visit. (ii) Any patient without
the initial histologic examination of OL and the diagnosis of
development of OSCC during the follow-up on site distantly
located from the site of the initial biopsy; (iii) Any patient with a
follow-up period of less than 12 months after initially being
diagnosed with OL. (iv) Any patient with the clinical apparence
and histologic features of oral white or predominantly white
benign diseases, e.g. leukoedema, linea alba, leukokeratosis; and
other potentially malignant diseases, e.g. lichen planus, discoid
lupus erythematosus. All of the patients gave written informed
consent in accordance with institutional guidelines and this study
was approved by the institutional review board of Ninth People’s
Hospital, SJTU-SM.
Histologic examination
All the study participants underwent biopsy. The biopsy was
fixed in formalin, embedded in paraffin, and processed for routine
histologic examination. The histologic examination of all subjects
was determined according to the WHO criteria [22] by oral
pathologist from the Department of Oral Pathology, Ninth
People’s Hospital, SJTU-SM. According to the binary system of
grading oral dysplasia newly proposed by the WHO [7],
reexamination of all the cases confirmed the diagnosis and grade
of oral epithelial dysplasia. The cytology (a total of 9) and
architecture (a total of 7) criteria for oral dysplasia were as
previously described in literature [23]. We reclassified all cases as
low-grade dysplasia and high-grade dysplasia in the current study.
Classification of a lesion as low-grade was based on the
observation of fewer than 5 cytological changes or fewer than 4
architectural changes. Classification of a lesion as high-grade was
based on the observation of at least 5 cytological changes and 4
architectural changes.
Statistical Analysis
In the current study, malignant transformation versus non-
transformation of OL was considered to be the surrogate for the
clinical outcome of the patients. Follow-up period was defined as
the interval from the time when patient underwent first biopsy to
the nontransformation of last consultation (for censored observa-
tions) or to malignant transformation (for uncensored observa-
tions). If the subject had any worsen changes in clinical features
noted during the follow-up, sequential biopsy was performed and
the biopsy with the grade of dysplasia was taken for coding. The
subjects who underwent 1 time biopsy, 2 times biopsies, and
multiple (.=3) times biopsies were divided into corresponding 3
groups. Difference between groups and factors was compared by
using Kruskal-Wallis test and their relationship was determined by
using Pearson correlation analysis. Oral cancer-free survival
(OCFS) was determined by using the Kaplan-Meier method and
log-rank test. To identify risk factors in predicting risk of OL
transformation, Cox proportional hazards models were utilized.
Hazard ratio (HR) with 95% confidence interval (CI) and P value
were reported. All tests were two sided, and P values of ,0.05
were accepted for statistical significance. Statistical analyses were
performed using the software packages SPSS version 16.0 for
Windows (SPSS Inc., Chicago, Ill).
Results
Patient Characteristics
A total of 320 patients with OL were identified in the current
study for whom a mean follow-up of 5.1 years (range, 1–20 years)
was available. Of these, 57 (17.8%) patients developed early stage
I/II OSCC, with a mean interval of developing OSCC of 4.5
years. The mean interval of 27 cases of low-grade dysplasia was
5.8 years compared with that of 3.3 years of 30 cases of high-grade
dysplasia (Student’s t-test, P=0.018). These patients were 175
females and 145 males (ratio F:M=1.2:1) with the average (SD)
age at initial diagnosis was 54.1 (11.6) years (range 21–83). The
lateral/ventral tongue was affected in 121 (37.8%) patients,
followed by the buccal mucosa (29.1%), dorsal tongue (19.4%),
gingiva (8.1%), palate (3.8%). As OL were predominantly located
on the lateral/ventral tongue, lesion sites were grouped as lateral/
ventral tongue and others for an analysis of transformation risk. To
analyze the transformation risk of the age, the cohort of patients
were classified as the elderly (.60 years) and non-elderly (,=60
years) in this study. We found that 91 (28.4%) lesions were high-
grade dysplasia and only 19 (5.9%) lesions were non-homogenous
type in this series (Fig. 1).
Oral cancer-free survival analysis of risk factors in OL
transformation
To investigate the time to malignant event of OL, the oral
cancer-free survival (OCFS) by Kaplan-Meier method using
clinicopathological factors was performed and OCFS rate at years
3, 5 were determined (Table 1). Age, lesion site, lesion type, and
dysplasia were significant risk factors by log-rank test (Fig. 2). For
all the 320 subjects, the 3-year and 5-year OCFS was 86.6% and
82.0%, respectively. For patient’ age, elderly patient (5-year OCFS
rate, 72.6%) had a higher malignant incidence than non-elderly
patient (5-year OCFS rate, 84.9%) (P=0.021, log-rank test). For
anatomical site, it is evident that the lesion at lateral/ventral
tongue (5-year OCFS rate, 73.5%) had a much higher malignant
incidence than that at other sites (5-year OCFS rate, 88.0%)
(P,0.001, log-rank test). In addition, non-homogenous OL (5-year
OCFS rate, 54.2%) had a much higher malignant incidence than
homogenous OL (5-year OCFS rate, 84.2%) (P=0.001, log-rank
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year OCFS rate, 59.0%) was associated with an obviously
increased malignant incidence compared with low-grade dysplastic
lesion (5-year OCFS rate, 90.5%) (P,0.001, log-rank test). Of
interest is that the OCFS curve showed much high incidences of
malignant events for patients with high-grade dysplasia occured
during the first 2–3 years of follow-up by Kaplan-Meier analysis
(Fig. 2E).
Figure 1. Oral cancer development in patient with leukoplakia. Malignant process of (A) a case of a homogenous leukoplakia and (B) a case
of a non-homogenous verrucous leukoplakia.
doi:10.1371/journal.pone.0034773.g001
Table 1. Oral cancer-free survival (OCFS) analysis of risk factors in transformation of oral leukoplakia.
Characteristic Malignant events/n OCFS rate at 3 yr (SE) OCFS rate at 5 yr (SE) P
All patients 57/320 0.866 (0.024) 0.820 (0.029)
Gender 0.141
Female 37/175 0.865 (0.032) 0.814 (0.039)
Male 20/145 0.867 (0.037) 0.830 (0.044)
Age (yr) 0.021
,=60 38/228 0.880 (0.027) 0.849 (0.031)
.60 19/92 0.827 (0.052) 0.726 (0.071)
Lesion site ,0.001
Other sites 19/199 0.920 (0.024) 0.880 (0.032)
Lateral/ventral tongue 38/121 0.789 (0.046) 0.735 (0.052)
Lesion type 0.001
Homogenous 49/301 0.877 (0.024) 0.842 (0.029)
Non-homogenous 8/19 0.697 (0.116) 0.542 (0.132)
Epithelial dysplasia ,0.001
Low grade 27/229 0.937 (0.020) 0.905 (0.026)
High grade 30/91 0.675 (0.065) 0.590 (0.073)
Smoking 0.423
Never 33/194 0.868 (0.031) 0.816 (0.039)
Past and present 11/86 0.888 (0.044) 0.888 (0.044)
Unknown 13/40
Alcohol intake 0.689
Never 32/196 0.875 (0.031) 0.835 (0.037)
Past and present 12/84 0.876 (0.045) 0.847 (0.052)
Unknown 13/40
SE, standard error of the mean.
doi:10.1371/journal.pone.0034773.t001
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transformation
To evaluate the risk of OL malignant transformation,
clinicopathological factors were analyzed by the Cox proportional
hazards model (Table 2). On univariate analysis, age, lesion site,
lesion type and dysplasia but not gender, smoking and alcohol
intake were found to be significantly correlated with the OL
transformation. To further assess the influence of each significant
factor, we then did multivariate analysis and all 4 factors retained
statistical significance. On multivariate analysis, elderly patient
was associated with 2.17-fold (95% CI, 1.18–4.00; P=0.013)
increased the risk of transformation compared with non-elderly
patient. The lesion located at lateral/ventral tongue was associated
with 2.84-fold (95% CI, 1.55–5.18; P=0.001) increased the risk of
transformation compared with other oral sites. In addition, the
adjusted OR for transformation was 2.55 for non-homogenous OL
(95% CI, 1.15–5.68; P=0.022) and 2.88 for high-grade dysplasia
(95%CI, 1.64–5.07; P,0.001), respectively.
Association between multiple times biopsies and factors
To analyse the multiple times oral biopsies contributing to early
detection of malignant event, association between number of
biopsy times and factors and outcome was performed by using
Kruskal-Wallis test and Pearson correlation analysis. The
distribution of number of biopsy times of the study subjects is
listed in Table 3. Significant difference in age, lesion site, lesion
type, dysplasia and outcome was found (all P,0.05, Kruskal-
Wallis test), whereas differences in gender, smoking and alcohol
intake were not observed (all P.0.05, Kruskal-Wallis test) between
the 3 groups of varying times biopsies (Table 4). Consistently,
positive correlation between the 3 groups and age, lesion site,
lesion type, dysplasia and outcome was significant (all P,0.05,
Pearson’s correlation test; Table 4).
Discussion
To the best of our knowledge, the current study is the largest
cohort of patients with OL who received long-term follow-up
focusing on to determine the clinicopathological factors predictive
of outcome, and this is the first to identify which subpopulation of
high-risk patients with OL was suggested to undergo multiple
biopsies and histologic examination in order to detect early
malignant events for more aggressive management. For all the 320
subjects, the 3-year and 5-year OCFS was 86.6% and 82.0%,
respectively. Multivariate analysis revealed that age, lesion site,
lesion type, dysplasia were independent risk factors for OL
malignant transformation. Together, elderly patients with OL
located at lateral/ventral tongue and who had non-homogenous
lesion with high-grade dysplasia correlated much higher risk of
transformation. It highlights the importance of utilizing sequential
biopsies and histologic examination to confirm the clinical
diagnosis for any suspicious these high-risk lesions for early
detection of malignant event.
In the current series, we considered the malignant interval
elapsed from the initial diagnosis of OL to cancer development. In
this context, we excluded any patient with diagnosis of OL in
concomitant with oral cancer at the first visit, as well as these with
a follow-up of less than 12 months after initially diagnosis with OL.
A short interval from diagnosis of OL to that of cancer could lead
to overestimation of the true occurrence of OL malignant
transformation and potentially suggest these 2 diseases were
synchronous. A frequency (17.8%) of transformation of OL into
oral cancer was noted in this study, within the range reported in
the literature for OL [15]. Herein, differences in treatments
administered to the patients with OL were not observed, and
Cochrane Database of Systematic Review demonstrate no evidence of
effective management in preventing the transformation of OL into
cancer [24–28].
Figure 2. Oral cancer-free survival analysis. (A) by the cohort of overall patients; (B) by patient aged .60 years and ,=60 years; (C) by lateral/
ventral tongue and other oral sites; (D) by non-homogenous and homogenous lesion; (E) by low-grade and high-grade dysplasia.
doi:10.1371/journal.pone.0034773.g002
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and clinical factors and oral habits have been accessed in the
previous reports, the results from the different study populations
vary. Because of our large cohort of patients with OL, it was
possible to perform robust statistical analysis to identify predictors
of outcome. We found that patient age is an important risk factor
affecting malignant outcome, which may be correlated with
genetic susceptibility contributing to the phenotype [18]. The risk
of transformation was higher in the elderly patients than in the
non-elderly patients in the current study. The risk of transforma-
tion of lateral/ventral tongue OL and non-homogenous OL was
higher than at other sites and homogenous OL, respectively.
These findings were consistent with the risk for oral location and
clinical type of malignant transformation in the earlier reports
[16,29,30].
Smoking and alcohol intake play important roles in the
development of OL may be generally accepted, but the roles of
these in the malignant transformation of OL remains controversial
and as yet unclear. The studies by Silverman et al [19] and
Schepman et al [20] reported an increased risk of transformation
for the non-smoker, whereas the study by Shiu et al [17] and our
current study showed that smoking was not a significant risk factor
in OL transformation. Also, alcohol intake was also not a
significant risk factor for OL transformation [17,18]. Further
studies are needed to investigate the potential roles of these risk
factors in the malignant process of OL.
As is well-known, the histologic assessment of OL transforma-
tion is imperfect, but it has not been possible to do without it to
date [7]. Actually, many clinicians currently rely on the oral
epithelial dysplasia present in patients with OL as an important
indicator of oral cancer risk in routine practice. Although it had
been shown that patients with oral dysplastic lesions more frequent
develop oral cancer than those with non-dysplastic lesions, the
different grades of dysplastic OL is significantly associated with
malignant transformation is conflicting [10–13]. At a workshop
coordinated by the WHO Collaborating Centre for Oral Cancer
and Precancer in the UK issues related to potentially malignant
disorders of oral mucosa, a latest proposal was recommended as
the two class classification (no/questionable/mild - low grade
dysplasia; moderate/severe - high grade dysplasia); this view was
Table 2. Cox regression analysis of risk factors in transformation of oral leukoplakia.
Univariate analysis Multivariate analysis
Variate HR (95% CI) P HR (95% CI) P
Gender
Female 1.00
Male 0.66 (0.38–1.15) 0.145
Age (yr)
,=60 1.00 1.00
.60 1.91 (1.09–3.35) 0.024 2.17 (1.18–4.00) 0.013
Lesion site
Other sites 1.00 1.00
Lateral/ventral tongue 3.38 (1.94–5.87) ,0.001 2.84 (1.55–5.18) 0.001
Lesion type
Homogenous 1.00 1.00
Non-homogenous 3.34 (1.57–7.13) 0.002 2.55 (1.15–5.68) 0.022
Epithelial dysplasia
Low grade 1.00 1.00
High grade 4.33 (2.55–7.36) ,0.001 2.88 (1.64–5.07) ,0.001
Smoking
Never 1.00
Past and present 0.76 (0.38–1.50) 0.427
Alcohol intake
Never 1.00
Past and present 0.87 (0.45–1.70) 0.874
HR, Hazard Ratio. CI: confidence interval.
doi:10.1371/journal.pone.0034773.t002
Table 3. Number of biopsy times of the study subjects.
Oral leukoplakia Total UT case MT case
All patients, n (%) 320 263 (82.2) 57 (17.8)
No. of biopsy times
1 127 127 (48.3) –
2 114 91 (34.6) 23 (40.4)
3 51 27 (10.3) 24 (42.1)
4 14 10 (3.8) 4 (7.0)
5 10 5 (1.9) 5 (8.8)
6 2 1 (0.4) 1 (1.8)
7 2 2 (0.8) –
UT, untransformed case. MT, malignant transformed case.
doi:10.1371/journal.pone.0034773.t003
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dysplasia may enhance the likelihood of agreement between
pathologists [7]. Kujan et al [23] determined the new binary
system of grading dysplasia and supported this view.
In the current study, we have explored the biological
significance of this binary system of grading oral dysplasia in
predicting the malignant risk of OL transformation in a
longitudinal large cohort, and supports the utilization of high-
grade dysplasia as a significant indicator for predicting risk. This
result was in agreement with that in our recent studies [31,32]. It is
noteworthy that high malignant incidences for patients with high-
grade dysplasia occured during the first 2–3 years of follow-up, in
similar with the findings showed by Ho et al [18] and Silverman et
al [19]. This suggests that periodic follow-up during the first 2–3
years for patients with high grade dysplastic OL is important to
detect early events of malignant transformation.
The another important finding in our study was that we
reported our experience in the early detection of malignant events.
We established significant positive correlation between the
sequential multiple biopsies and age, lesion site, lesion type,
dysplasia and outcome of malignant transformation, and identified
a subpopulation of high-risk patients with OL was suggested to
undergo multiple biopsies and histologic examination. This
suggested that utilizing multiple biopsies and histologic examina-
tion to confirm the clinical diagnosis for any suspicious these high-
risk lesions contribute to detect early malignant event.
In summary, the significance of the new binary system of
grading oral dysplasia proposed by the WHO in the predicting risk
of OL transformation was evaluated. Elderly patients with OL
located at lateral/ventral tongue and who had non-homogenous
lesion with high-grade dysplasia correlated much higher risk of
transformation. This high-risk subpopulation was suggested to
undergo multiple biopsies and histologic examination contributing
to early detection of malignant event.
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Table 4. Association between multiple times biopsies and factors and outcome.





All patients, n (%) 320 127 (39.7) 114 (35.6) 79 (24.7)
Age (yr) 0.048 0.013
,50 106 49 (46.2) 36 (34.9) 20 (18.9)
50–59 114 47 (41.2) 36 (31.6) 31 (27.2)
60–69 71 25 (35.2) 28 (39.4) 18 (25.4)
.=70 29 6 (20.7) 13 (44.8) 10 (34.5)
Gender 0.065 0.030
Female 175 63 (36.0) 60 (34.3) 52 (29.7)
Male 145 64 (44.1) 54 (37.2) 27 (18.6)
Lesion site ,0.001 ,0.001
Lateral/ventral tongue 121 19 (15.7) 56 (46.3) 46 (38.0)
Other oral sites 199 108 (54.3) 58 (29.1) 33 (16.6)
Lesion type 0.005 0.001
Homogenous 301 125 (41.5) 107 (35.5) 69 (22.9)
Non-homogenous 19 2 (10.5) 7 (36.8) 10 (52.6)
Epithelial dysplasia ,0.001 ,0.001
Low grade 229 108 (47.2) 78 (34.1) 43 (18.8)
High grade 91 19 (20.9) 36 (39.6) 36 (39.6)
Smoking 0.572 0.410
Never 194 84 (43.3) 66 (34.0) 44 (22.7)
Past and present 86 43 (50.0) 25 (29.1) 18 (20.9)
Unknown 40
Alcohol intake 0.367 0.161
Never 196 94 (48.0) 62 (31.6) 40 (20.4)
Past and present 84 33 (39.3) 29 (34.5) 22 (26.2)
Unknown 40
Outcome ,0.001 ,0.001
Cancer-free events 263 127 (48.3) 91 (34.4) 45 (17.1)
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